SiS-H App for Smoking Cessation

N/A

Recruiting

Led By Bettina Hoeppner, PhD, MS

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at baseline and week 20 (3 months after end of treatment)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new app-based smoking cessation treatment called SiS-H for people with HIV who smoke. Participants will be compared to those using the National Cancer Institute's app "QuitGuide".

Who is the study for?

This trial is for adults over 18 who are HIV positive, smoke at least weekly, and have smoked more than 100 cigarettes in their lifetime. Participants must be receiving regular HIV care and willing to attempt quitting smoking as part of the study. They also need to allow access to their medical records and app usage data.

What is being tested?

The trial is testing 'SiS-H,' an integrated mobile health app designed for smoking cessation in people with HIV, against the National Cancer Institute's 'QuitGuide' app. It aims to assess how feasible, acceptable, and effective SiS-H is compared to QuitGuide through a pilot randomized controlled trial.

What are the potential side effects?

Since this trial involves using smartphone apps for smoking cessation rather than medication or medical procedures, there are no direct side effects from interventions like you would expect with drugs or surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at baseline and week 20 (3 months after end of treatment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at baseline and week 20 (3 months after end of treatment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and week 20 (3 months after end of treatment) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

App usage

Secondary study objectives

App usability rating, System Usability Scale (SUS)

Attitudes Towards Smoking Scale (ATS) - adverse effects of smoking sub-scale

Attitudes Towards Smoking Scale (ATS) - pleasure of smoking sub-scale

+13 more

Other study objectives

30-day point prevalence abstinence (PPA) - biochemically verified

30-day point prevalence abstinence (PPA) - self-reported

HIV Medication Adherence

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Smiling instead of Smoking - HIVExperimental Treatment1 Intervention

Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and will be asked to use it for 8 weeks while they quit smoking.

Group II: QuitGuideActive Control1 Intervention

Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking.

Do I qualify?Apply below to find out